Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case-control study of leukemia and diagnostic radiation exposure.
Yuasa H, Hamajima N, Ueda R, Ohno R, Asou N, Utsunomiya A, Ogura M, Takigawa N, Ueda T, Hiraoka A, Matsuda S, Kuraishi Y, Nishikawa K, Uike N, Takeshita A, Takemoto Y, Shimazaki C, Sakamaki H, Ino T, Matsushima T, Kuriyama K, Hirai H, Naoe T, Tsubaki K, Takahashi I, et al. Yuasa H, et al. Among authors: ino t. Int J Hematol. 1997 Apr;65(3):251-61. doi: 10.1016/s0925-5710(96)00556-7. Int J Hematol. 1997. PMID: 9114596
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group.
Ueda T, Miyawaki S, Asou N, Kuraishi Y, Hiraoka A, Kuriyama K, Minami S, Ohshima T, Ino T, Tamura J, Kanamaru A, Nishikawa K, Tanimoto M, Oh H, Saito K, Nagata K, Naoe T, Yamada O, Urasaki Y, Sakura T, Ohno R. Ueda T, et al. Among authors: ino t. Int J Hematol. 1998 Oct;68(3):279-89. doi: 10.1016/s0925-5710(98)00075-9. Int J Hematol. 1998. PMID: 9846012 Clinical Trial.
Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG).
Tanimoto M, Miyawaki S, Ino T, Kyo T, Sakamaki H, Naoe T, Hiraoka A, Asou N, Ohshima T, Tsubaki K, Kuriyama K, Ueda T, Minamil S, Okabe K, Saito H, Murakami H, Hirano M, Dohy H, Onozawa Y, Suzuki H, Ohno R. Tanimoto M, et al. Among authors: ino t. Int J Hematol. 1998 Dec;68(4):421-9. doi: 10.1016/s0925-5710(98)00084-x. Int J Hematol. 1998. PMID: 9885441 Clinical Trial.
Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia.
Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, Kamada N, Kubota Y, Nakamura H, Shimazaki C, Horiike S, Kodera Y, Saito H, Ueda R, Wiemels J, Ohno R. Naoe T, et al. Among authors: ino t. Clin Cancer Res. 2000 Oct;6(10):4091-5. Clin Cancer Res. 2000. PMID: 11051261
Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis.
Ohnishi K, Ino T, Kishimoto Y, Usui N, Shimazaki C, Ohtake S, Taguchi H, Kusumoto S, Kuriyama K, Hotta T, Ohno R. Ohnishi K, et al. Among authors: ino t. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S59-64. doi: 10.1007/s002800100307. Cancer Chemother Pharmacol. 2001. PMID: 11587369 Clinical Trial.
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study.
Takeuchi J, Kyo T, Naito K, Sao H, Takahashi M, Miyawaki S, Kuriyama K, Ohtake S, Yagasaki F, Murakami H, Asou N, Ino T, Okamoto T, Usui N, Nishimura M, Shinagawa K, Fukushima T, Taguchi H, Morii T, Mizuta S, Akiyama H, Nakamura Y, Ohshima T, Ohno R. Takeuchi J, et al. Among authors: ino t. Leukemia. 2002 Jul;16(7):1259-66. doi: 10.1038/sj.leu.2402526. Leukemia. 2002. PMID: 12094249 Clinical Trial.
527 results